Q4 2024 · 13F-HR
Rhenman & Partners Asset Management ABholdings as filed
Filed 2025-02-13 · accession 0001213900-25-013150
$972.9M
Reported value
92
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $39.7M | 4.08% | 444,000 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $35.1M | 3.61% | 45,450 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $33.8M | 3.48% | 420,345 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $33.4M | 3.43% | 64,000 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $31.0M | 3.18% | 43,457 | Common | SOLE |
| 91324P102 | UNH | UNITED HEALTH GROUP INC | $30.6M | 3.15% | 60,530 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $27.8M | 2.86% | 150,041 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO. INC | $27.6M | 2.84% | 277,500 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $26.5M | 2.72% | 471,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $25.0M | 2.56% | 197,700 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $23.6M | 2.43% | 255,500 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $22.1M | 2.27% | 124,150 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $21.6M | 2.22% | 78,385 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $21.5M | 2.21% | 269,500 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $20.1M | 2.07% | 50,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $19.8M | 2.04% | 1,761,192 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $19.5M | 2.01% | 123,410 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $19.4M | 2.00% | 34,117 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $18.9M | 1.94% | 123,700 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $18.3M | 1.88% | 1,362,421 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $17.9M | 1.84% | 145,500 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $16.5M | 1.69% | 250,623 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $15.2M | 1.56% | 595,000 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $14.9M | 1.53% | 57,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $14.7M | 1.51% | 176,000 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $14.7M | 1.51% | 63,952 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $14.5M | 1.49% | 128,000 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $14.0M | 1.44% | 55,230 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $13.7M | 1.41% | 100,317 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $13.1M | 1.35% | 124,000 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $12.1M | 1.24% | 53,750 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $12.0M | 1.23% | 267,500 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $11.8M | 1.22% | 195,482 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $10.9M | 1.12% | 47,900 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $10.7M | 1.10% | 839,131 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $10.6M | 1.09% | 115,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $10.4M | 1.07% | 122,600 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $10.3M | 1.06% | 34,379 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $10.0M | 1.02% | 34,200 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $9.1M | 0.94% | 1,235,448 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $9.1M | 0.94% | 170,000 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $8.7M | 0.90% | 41,900 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $8.5M | 0.88% | 23,150 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $8.1M | 0.84% | 15,640 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $8.1M | 0.83% | 22,500 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $7.9M | 0.81% | 262,500 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $7.4M | 0.76% | 212,500 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $7.0M | 0.72% | 149,250 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $6.2M | 0.64% | 195,591 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $6.0M | 0.62% | 52,750 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $5.7M | 0.59% | 29,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $5.7M | 0.58% | 72,500 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $5.5M | 0.57% | 30,900 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $5.5M | 0.56% | 36,531 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $5.5M | 0.56% | 290,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $5.2M | 0.53% | 56,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $4.5M | 0.46% | 195,750 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $4.3M | 0.44% | 50,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $4.2M | 0.44% | 61,500 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $4.2M | 0.43% | 1,915,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $4.0M | 0.41% | 17,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $3.7M | 0.38% | 23,750 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $3.6M | 0.37% | 90,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $3.6M | 0.37% | 145,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $3.5M | 0.36% | 1,000,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $3.3M | 0.34% | 43,500 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $3.1M | 0.32% | 74,500 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $3.1M | 0.32% | 232,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $3.0M | 0.31% | 73,755 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $3.0M | 0.31% | 155,500 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $2.8M | 0.29% | 542,500 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $2.7M | 0.28% | 14,850 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY IN | $2.7M | 0.28% | 314,526 | Common | SOLE |
| 03763A207 | ASTH | ASTRANA HEALTH INC | $2.5M | 0.26% | 80,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $2.5M | 0.26% | 114,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $2.4M | 0.24% | 38,000 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP INC | $2.4M | 0.24% | 121,189 | Common | SOLE |
| 58506Q109 | MEDP | MEDPACE HLDGS INC | $2.3M | 0.23% | 6,800 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.2M | 0.23% | 77,999 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $2.1M | 0.22% | 36,315 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $2.1M | 0.22% | 82,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $1.9M | 0.19% | 460,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.7M | 0.18% | 58,278 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.5M | 0.16% | 116,250 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $1.4M | 0.14% | 35,000 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $1.3M | 0.13% | 61,826 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $1.3M | 0.13% | 9,000 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $832,586 | 0.09% | 178,284 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $781,920 | 0.08% | 3,000 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $770,251 | 0.08% | 126,064 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY INC | $545,188 | 0.06% | 13,750 | Common | SOLE |
| 09073M104 | TECH | BIO-TECHNE CORP | $216,090 | 0.02% | 3,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.